Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.6500 (-3.95%) ($3.6500 - $3.6500) on Fri. Jan. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.52% (three month average) | RSI | 32 | Latest Price | $3.6500(-3.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.8% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) ARKK(82%) ARKG(81%) IWO(81%) IBUY(80%) | Factors Impacting CGEN price | CGEN will decline at least -2.26% in a week (0% probabilities). VIXM(-72%) VXX(-52%) UUP(-22%) UNG(-15%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.26% (StdDev 4.52%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.98(-318.63%) | Resistance Level | $4.12 | 5 Day Moving Average | $3.79(-3.69%) | 10 Day Moving Average | $3.93(-7.12%) | 20 Day Moving Average | $4.12(-11.41%) | To recent high | -49.1% | To recent low | 0% | Market Cap | $302m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |